Aspire Biopharma Holdings, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 05/12/2025 | 1.49 M | $101.13 K | 100.00% | 3.11% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 1.05 M | $71.09 K | 100.00% | 2.18% |
SABA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 983.60 K | $71.80 K | 100.00% | 2.05% |
LINDEN ADVISORS LP | 05/15/2025 | 900.00 K | $65.70 K | 100.00% | 1.87% |
ARISTEIA CAPITAL LLC | 05/16/2025 | 681.52 K | $49.75 K | 100.00% | 1.42% |
VERITION FUND MANAGEMENT LLC | 05/15/2025 | 432.76 K | $29.30 K | 100.00% | 0.90% |
PERISCOPE CAPITAL INC. | 05/13/2025 | 408.57 K | $29.83 K | 100.00% | 0.85% |
BARCLAYS PLC | 05/15/2025 | 350.00 K | $31.00 K | 100.00% | 0.73% |
CLEAR STREET LLC | 05/15/2025 | 331.06 K | $22.41 K | 100.00% | 0.69% |
TACONIC CAPITAL ADVISORS LP | 05/15/2025 | 300.00 K | $20.31 K | 100.00% | 0.62% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 275.00 K | $18.62 K | 100.00% | 0.57% |
ALBERTA INVESTMENT MANAGEMENT CORP | 05/08/2025 | 250.00 K | $16.93 K | 100.00% | 0.52% |
D. E. SHAW & CO., INC. | 05/15/2025 | 200.00 K | $13.54 K | 100.00% | 0.42% |
WOLVERINE ASSET MANAGEMENT LLC | 05/12/2025 | 195.94 K | $13.27 K | 100.00% | 0.41% |
CONTEXT CAPITAL MANAGEMENT, LLC | 05/05/2025 | 175.00 K | $11.85 K | 100.00% | 0.36% |
POLAR ASSET MANAGEMENT PARTNERS INC. | 05/15/2025 | 138.54 K | $10.11 K | 100.00% | 0.29% |
LMR PARTNERS LLP | 05/15/2025 | 125.00 K | $8.46 K | 100.00% | 0.26% |
WHITEBOX ADVISORS LLC | 05/15/2025 | 118.75 K | $8.04 K | 100.00% | 0.25% |
CLEAR STREET DERIVATIVES LLC | 05/15/2025 | 106.00 K | $7.18 K | 100.00% | 0.22% |
JPMORGAN CHASE & CO | 05/12/2025 | 100.00 K | $6.77 K | 100.00% | 0.21% |
CAAS CAPITAL MANAGEMENT LP | 05/01/2025 | 75.00 K | $5.08 K | 100.00% | 0.16% |
BLUE OWL CAPITAL HOLDINGS LP | 05/15/2025 | 50.00 K | $3.50 K | 100.00% | 0.10% |
PICTON MAHONEY ASSET MANAGEMENT | 05/07/2025 | 50.00 K | $3.00 K | 100.00% | 0.10% |
MINT TOWER CAPITAL MANAGEMENT B.V. | 05/15/2025 | 25.00 K | $15.00 K | 100.00% | 0.05% |
OMERS ADMINISTRATION CORP | 05/14/2025 | 25.00 K | $1.83 K | 100.00% | 0.05% |
ATHOS CAPITAL LTD | 05/14/2025 | 21.38 K | $12.00 K | 100.00% | 0.04% |
FLOW TRADERS U.S. LLC | 05/14/2025 | 14.19 K | $1.00 K | 100.00% | 0.03% |
05/01/2025 | 70 | $4 | 100.00% | 0.00% | |
FARTHER FINANCE ADVISORS, LLC | 04/14/2025 | 10 | $1 | 100.00% | 0.00% |
Aspire Biopharma Holdings, Inc. institutional Ownership - FAQ's
During the previous two years, 27 institutional investors and hedge funds held shares of Aspire Biopharma Holdings, Inc.. The most heavily invested institutionals were:
HIGHBRIDGE CAPITAL MANAGEMENT LLC: 1.49 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 1.05 M
Saba Capital Management, L.P.: 983,603
LINDEN ADVISORS LP: 899,999
ARISTEIA CAPITAL LLC: 681,516
Verition Fund Management LLC: 432,757
17.89% of Aspire Biopharma Holdings, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 8.60 M shares in the last 24 months. This purchase volume represents approximately $344.04 K in transactions.